# Buprenorphine/Raltegravir Pharmacokinetic Interaction Study

> **NCT00858962** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 12 (actual)

## Conditions studied

- HIV Infection
- HIV Infections

## Interventions

- **DRUG:** Raltegravir

## Key facts

- **NCT ID:** NCT00858962
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-11-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00858962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00858962, "Buprenorphine/Raltegravir Pharmacokinetic Interaction Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00858962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*